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Abstract
Background: The Global Immunization Vision and Strategy (GIVS) (2006-2015) aims to reach and sustain high
levels of vaccine coverage, provide immunization services to age groups beyond infancy and to those currently
not reached, and to ensure that immunization activities are linked with other health interventions and contribute
to the overall development of the health sector.
Objective: To examine mid-term progress (through 2010) of the immunization coverage goal of the GIVS for 194
countries or territories with special attention to data from 68 countries which account for more than 95% of all
maternal and child deaths.
Methods: We present national immunization coverage estimates for the third dose of diphtheria and tetanus
toxoid with pertussis (DTP3) vaccine and the first dose of measles containing vaccine (MCV) during 2000, 2005 and
2010 and report the average annual relative percent change during 2000-2005 and 2005-2010. Data are taken from
the WHO and UNICEF estimates of national immunization coverage, which refer to immunizations given during
routine immunization services to children less than 12 months of age where immunization services are recorded.
Results: Globally DTP3 coverage increased from 74% during 2000 to 85% during 2010, and MCV coverage
increased from 72% during 2000 to 85% during 2010. A total of 149 countries attained or were on track to achieve
the 90% coverage goal for DTP3 (147 countries for MCV coverage). DTP3 coverage ≥ 90% was sustained between
2005 and 2010 by 99 countries (98 countries for MCV). Among 68 priority countries, 28 countries were identified as
having made either insufficient or no progress towards reaching the GIVS goal of 90% coverage by 2015 for DTP3
or MCV. DTP3 and MCV coverage remained < 70% during 2010 for 16 and 21 priority countries, respectively.
Conclusion: Progress towards GIVS goals highlights improvements in routine immunization coverage, yet it is
troubling to observe priority countries with little or no progress during the past five years. These results highlight
that further efforts are needed to achieve and maintain the global immunization coverage goals.
Keywords: immunization coverage, statistics, immunization, monitoring, Global Immunization Vision and Strategy
(GIVS)
Background
In response to challenges in global immunization follow-
ing tremendous success experienced during the 1980s,
the United Nations Children’s Fund (UNICEF), the
World Health Organization (WHO) and partners devel-
oped the Global Immunization Vision and Strategy
(GIVS) for the years 2006-2015 [1,2]. The GIVS aims to
assist countries to protect more people against diseases
by expanding the reach of immunization to every eligi-
ble person, including those in age groups beyond
infancy, within a context in which immunization is high
on national health agendas. The global strategy com-
prises four strategic areas with 24 component strategies
[1,2] from which countries can choose for implementa-
tion according to their specific needs. The four areas
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are: to immunise more people against more diseases; to
introduce a range of newly available vaccines and tech-
nologies; to integrate immunization other critical health
interventions; and to manage vaccination programmes
within the context of global interdependence.
Among the goals and targets to further prevent morbid-
ity and mortality from vaccine preventable diseases set
forth by GIVS was to increase national immunization cov-
erage to at least 90% by 2010 and to sustain such levels of
immunization coverage through 2015. Using WHO and
UNICEF estimates of national immunization coverage for
the third dose of diphtheria, tetanus toxoid and pertussis
vaccine (DTP3) and the first dose of measles containing
vaccine (MCV), we report the number of countries or ter-
ritories that have met the 90% goal by 2010 and progress
towards the GIVS coverage goal for those that did not
meet the goal by 2010.
Methods
Each year since 2000, WHO and UNICEF have jointly
reviewed, prepared and published estimates of national
immunization coverage for select vaccines. A detailed
explanation of the estimation methods is provided else-
where [3]. Briefly, reports by national authorities to WHO
and UNICEF and survey data from the published and grey
literature are reviewed. Based on these data, with due con-
sideration to potential biases and the views of local experts
(primarily national immunization system managers and
WHO/UNICEF regional and national staff), WHO and
UNICEF jointly estimate the most likely immunization
coverage levels for each country or territory. It is impor-
tant to emphasize that while the WHO and UNICEF esti-
mates are informed by data from national authorities and
may not differ from official government reported data,
they constitute an independent technical assessment by
WHO and UNICEF of the national routine immunization
system performance.
Immunization coverage levels are presented as the per-
centage of a target population that has been vaccinated.
For example, DTP3 coverage is calculated by dividing the
number of children receiving the third dose of DTP vac-
cine by the number of children who survived to their first
birthday. It is important to emphasize that the WHO and
UNICEF estimates of national immunization coverage
refer to immunizations given during routine immunization
services to children less than 12 months of age where such
services are recorded; not included are supplementary
immunization activities such as polio, tetanus and measles
campaigns. The WHO and UNICEF estimates are not the
result of a formal modeling exercise and no statistical or
mathematical models are used, with the exception that
coverage for the first dose of DTP vaccine (DTP1) is based
on the result of a simple ordinary least squares model of
the relationship between DTP1 and DTP3 in those
instances where DTP1 data are missing or where a coun-
try reports DTP1 coverage below DTP3. While there are
frequently general trends in immunization coverage levels,
no attempt is made to fit data points with smoothing tech-
niques or time series methods though the estimation pro-
cess does allow for interpolation within the time series
and extrapolation at the end of the time series. To better
ensure the consistency and replicability of the estimates
and the transparency of methods, WHO and UNICEF
began representing the data, information and decision
heuristics in 2010 using a formal knowledge representa-
tion and reasoning system, described in detail elsewhere
[4].
We report global and regional (Millennium Develop-
ment Goal regions; available at http://www.un.org/mil-
lenniumgoals/index.shtml) DTP3 and MCV coverage.
Global and regional averages are obtained by multiplying
the country-specific immunization coverage and a popu-
lation weight for each country where the weight is the
country-specific proportion of the global (or regional)
total population. Population estimates of the number of
surviving infants for each country are obtained from the
United Nations Population Division [5].
We report the number of countries or territories that
reached the 90% goal by 2010 and examine progress
towards the GIVS coverage goal by 2015 for those coun-
tries that did not attain the goal by 2010. In addition to
reporting for 194 countries or territories, we highlight the
coverage data and GIVS progress for 68 priority countries
where more than 95% of all maternal and child deaths
occur. These 68 priority countries comprise a group
focused on by the Countdown to 2015: Tracking Progress
in Maternal, Newborn and Child Survival project, a global
effort supported by academics, governments, international
agencies, health care professional associations, donors and
nongovernmental organizations [6]. The Countdown uses
country-specific data to stimulate and support country
progress towards achieving the health-related MDGs.
The GIVS coverage goal is measured here against DTP3
and MCV national coverage data for 2010. Countries were
considered to have reached the objective if they attained
90% coverage by 2010. Progress towards the GIVS cover-
age goal by 2015 is based on national DTP3 and MCV
coverage data for 2000, 2005 and 2010 and the average
annual relative percent change during 2005-2010. For the
purposes here, countries and territories were classified as
“on track”, having made “insufficient progress” or “no pro-
gress” with regards to the 90% GIVS coverage goal in a
hierarchical manner as follows. For those with coverage
levels < 90% for 2010, countries were considered “on
track” for the objective for 2015 if the country had an
average annual rate of increase for the period 2005-2010
greater than or equal to that necessary to reach 90% by
2015 from the 2010 coverage level. We classified countries
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as having made “insufficient progress” if the average
annual rate of increase was less than that needed to reach
90% by 2015 for the period 2005-2010 or having made “no
progress” if coverage decreased or there was no change in
coverage for the period 2005-2010. Countries whose cov-
erage level was 80-89% during 2010 but who had either no
change in coverage or decreasing coverage during 2005-
2010 were classified as having made “insufficient progress”.
We classified countries with coverage levels of 90% or
greater during 2000 and 2005 but whose coverage during
2010 was < 90% on a case-by-case basis based on a review
of the immunization coverage time-series. The computed
average annual percent change was based on a linear rela-
tionship between the log of coverage and year during
2005-2010. All national coverage estimate data are based
on the 2010 revision (July 2011) of the WHO and UNICEF




Globally DTP3 coverage increased from 74% during 2000
to 85% during 2010; global MCV coverage increased from
72% during 2000 to 85% during 2010 (Table 1). Progress
towards the 90% GIVS coverage goal for all countries and
territories for DTP3 is shown in Figure 1 and that for
MCV is shown in Figure 2. More than three-quarters of
countries achieved at least 90% coverage for DTP3 (DTP3,
n = 149) or MCV (MCV, n = 148) during 2010, or were
on track to achieve at least 90% coverage for DTP3 or
MCV by 2015. Among 145 countries or territories who
attained 90% DTP3 coverage at some point during the
first five years of GIVS (2006-2010), DTP3 coverage ≥ 90%
was sustained for five years by 99 countries; 118 countries
achieved DTP3 coverage ≥ 90% for four of the five years
and 125 countries achieved DTP3 coverage ≥ 90% for
three of the five years. MCV coverage ≥ 90% was sustained
during the five year period by 98 countries; 112 countries
achieved MCV coverage ≥ 90% for four of the five years
and 123 countries achieved MCV coverage ≥ 90% for
three of the five years.
Nearly two-thirds of surviving infants unvaccinated
with DTP3 during 2010 resided in one of 45 countries
making either insufficient or no progress towards the
GIVS coverage goal for DTP3 (these 45 countries
accounted for one-third of surviving infants globally,
34.1% or 44,012,000 infants during 2010). Of these 45
countries, 41 countries were developing or least devel-
oped countries (according to World Bank classification
[7]) and 22 countries were located in Africa; similar
results were observed for MCV (42 of 46 countries,
accounting for 30.7% of infants unvaccinated with MCV
during 2010, with either insufficient or no progress were
classified as developing or least developed countries; 22
countries were located in Africa) (Table 2). Nonetheless,
immunization coverage has improved substantially
among developing or least developed countries since
2000.
Among 137 countries classified as developing or least
developed during 2000, 54 countries attained DTP3 cov-
erage ≥ 90% (average DTP3 coverage for developing
countries, 75%; for least developed countries, 61%) and
50 countries attained MCV coverage ≥ 90% (average
MCV coverage for developing countries, 73%; for least
developed countries, 59%); by 2010, 80 of 138 developing
or least developed countries reached 90% DTP3 coverage
(average DTP3 coverage for developing countries, 85%;
for least developed countries, 80%) and 76 countries
reached 90% MCV coverage (average MCV coverage for
developing countries, 86%; for least developed countries,
78%). Among 138 countries classified as developing or
least developed in 2010, 40% (n = 56) of countries sus-
tained DTP3 coverage ≥ 90% during the five year period
2006-2010 and 43% (n = 59) of countries sustained MCV
coverage ≥ 90% during the period. (N.B. The World Bank
country classification is reviewed and revised as needed
on an annual basis; therefore, the number of countries
classified as developing or least developed can change
from year to year.)
GIVS Progress among Priority Countries
Among 68 priority countries where more than 95% of
all maternal and child deaths occur, DTP3 coverage
Table 1 Global and regional averages of WHO and
UNICEF estimates of national routine immunization
coverage (%) with three doses of diphtheria and tetanus
toxoid with pertussis vaccine (DTP3) and with first dose
of measles containing vaccine (MCV), 2000, 2005, 2010
DTP3 coverage (%) MCV coverage (%)
MDG Region* 2000 2005 2010 2000 2005 2010
Sub-Saharan Africa 55 65 77 55 63 75
Northern Africa 95 96 97 93 95 96
Western Asia 84 84 86 85 83 85
Caucasus & Central Asia 93 93 94 93 94 94
Eastern Asia 85 87 99 84 87 99
South-Eastern Asia 80 82 88 81 84 91
Southern Asia 65 72 77 59 69 78
Oceania 65 66 62 66 66 59
Caribbean 73 78 79 76 77 76
Latin America 92 94 94 94 94 94
Developed 93 96 95 92 94 94
Global 74 79 85 72 78 85
* Millennium Development Goal Region, available at http://www.un.org/
millenniumgoals/index.shtml
Source: WHO and UNICEF estimates of national routine immunization
coverage, 2010 data revision (July 2011)
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ranged from 24% to 98% (median 68%) during 2000
and from 33% to 99% (median 84%) during 2010
(Additional File 1, Table S1). Sixteen priority countries
had DTP3 coverage estimates < 70% during 2010.
For MCV, coverage ranged from 24% to 99% during
2000 (median 71%) and from 46% to 99% during 2010
(median 83%) with 21 priority countries reporting
MCV coverage < 70% during 2010 (Additional File 2,
Table S2).
Among the 68 priority countries, accounting for more
than three-quarters of surviving infants globally (77.9%;
100,408,000 surviving infants) and more than 90% of sur-
viving infants unvaccinated with DTP3 (92.1%;
17,787,000) and MCV (91.5%; 17,474,000), 28 were iden-
tified as having made either insufficient or no progress
towards reaching the GIVS goal of 90% coverage for
DTP3; similarly, 28 of 68 countries made insufficient or
no progress for MCV coverage. Among 34 priority
Figure 1 Progress towards the Global Immunization Vision and Strategy (GIVS) 90% coverage goal for the third dose of diphtheria
and tetanus toxoid with pertussis vaccine.
Figure 2 Progress towards the Global Immunization Vision and Strategy (GIVS) 90% coverage goal for the first dose of measles
containing vaccine.
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countries identified with DTP3 coverage < 70% during
2000, DTP3 coverage remained below 70% for 14 coun-
tries in 2010, increased to 80-89% for 5 countries, and
increased to ≥ 90% for 8 countries by 2010. Similarly for
MCV, coverage remained below 70% during 2010 for 18
of 33 priority countries, increased to 80-89% for 5 coun-
tries, and increased to ≥ 90% for 4 countries with MCV
coverage < 70% during 2000.
Discussion
Levels and trends of immunization coverage are used to
monitor the performance of immunization services at
local, national and international levels; to guide eradica-
tion, elimination and control strategies for vaccine preven-
table diseases [8-10]; to identify areas of immunization
systems that may require additional resources and focused
attention [1,11]; and to inform decisions as to whether
new vaccines should be introduced into national and local
immunization systems [12]. Moreover, measles immuniza-
tion coverage is one of the indicators for tracking progress
towards achievement of the Millennium Development
Goals [13].
Although coverage targets should be kept in perspec-
tive and not distract from technically appropriate and
sustainable immunization programme activities [14], high
levels of immunization coverage are important to prevent
and control vaccine-preventable diseases. Our review of
national routine immunization coverage estimates
demonstrates that substantial progress has been made:
more than three-quarters of countries, accounting for
more than two-thirds of surviving infants globally in
2010, achieved at least 90% coverage during 2010 or were
on track to achieve ≥ 90% coverage for DTP3 and MCV
by 2015, and 118 countries maintained DTP3 coverage ≥
90% for four of the first five years of GIVS. The data sug-
gest that by 2015, 45 countries will not have reached the
90% target for DTP3 (46 countries for measles) if the
trend identified for 2005-2010 is correct and maintained.
These 45 countries account for an estimated two-thirds
of surviving infants unvaccinated with DTP3, most are
developing or least developed countries and roughly half
are located in Africa. Thus, developing and least devel-
oped countries continue to struggle to attain and main-
tain high coverage levels. Moreover, we identified 28 of
68 priority countries with either insufficient or no pro-
gress towards reaching the GIVS goal of 90% coverage
for DTP3 and for MCV coverage as of 2010; 22 of the 28
priority countries were located in Africa.
The role of GIVS to address the challenges of vaccina-
tion programmes has been described [1,2,15]. GIVS pro-
vides countries with a mechanism to identify critical
areas and resource needs. While many of the activities
supported by GIVS began prior to its development,
there is some evidence that these strategies (e.g., RED
[11], child health days [15], among others) are resulting
Table 2 Listing of countries with either insufficient or no
progress towards the GIVS coverage goal for the third
dose of diphtheria and tetanus toxoid with pertussis








Central African Republic** Bolivia**




Democratic Republic of the
Congo*
Costa Rica*
Dominican Republic* Côte d’Ivoire**
Equatorial Guinea** Cyprus*















Micronesia (Federated States of )* Mauritania*
Mozambique** Micronesia (Federated States of )*
Namibia* Mozambique**
Palau* Namibia*
Papua New Guinea** Palau**





South Africa** Solomon Islands**
Swaziland* Somalia*
Syrian Arab Republic* South Africa*
Tuvalu* Suriname*





* Countries making insufficient progress towards GIVS coverage goal of 90%.
** Countries making no progress towards GIVS coverage goal of 90%.
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in improved immunization system outcomes. Ultimately,
GIVS will be measured by how well countries, particu-
larly the developing and least developed countries, are
able to reduce vaccine preventable deaths, the total
costs of which have been estimated at US$76 (range: US
$23-110) billion including US$49 billion for mainte-
nance of current systems and $27 billion for scaling-up
in order to attain the GIVS goal of reducing mortality
due to vaccine preventable diseases by two-thirds by
2015 [16].
The review was based on the 2010 revision of the
WHO and UNICEF estimates of national immunization
coverage (completed in July 2011). The limitations of
these data have been described [3]. Perhaps most impor-
tantly, the quality of the estimates is determined by the
quality and availability of empirical data. Vaccination
coverage is comparatively easy to measure and two meth-
ods - administrative reports and surveys - have been
developed, each of which, when properly designed and
implemented, provides accurate and reliable direct mea-
sures of coverage levels. Implemented jointly (using each
measure for the same population), they provide a valida-
tion of coverage levels. However, both methods are sub-
ject to biases. In some instances, these may be identified
and corrected. In no instance are the WHO and UNICEF
estimates based on complete, consistent, multiple mea-
sures for an entire country and vaccine time series. In
some instances the WHO and UNICEF estimates are
based on complete administrative data validated by peri-
odic or occasional consistent survey findings. In others,
data are available from a single source - usually adminis-
trative data - and appear internally consistent over time
and across vaccines, while in some countries, administra-
tive data and survey results are inconsistent and in others
the administrative time series is incomplete, internally
inconsistent or both. The method also does not attempt
to triangulate coverage levels with disease incidence data.
For example, some countries may have high MCV cover-
age level estimates but suffer at the same time severe
measles outbreaks.
The WHO and UNICEF estimates are limited by the
absence of any articulation of uncertainty; as presented,
they appear equally precise and certain. The uncertainty
in the estimates is rooted in the accuracy and precision
of the empirical data (described above) and in the
choice and application of the heuristics. Because the
estimates are not based on a probability sample and
multiple measures are not considered as random var-
iants of a single population measure, limiting the uncer-
tainty to the amount of variation in the empirical data is
a challenge.
It is also important to emphasize that the WHO and
UNICEF estimates reflect (to every extent possible) cov-
erage levels attained through routine immunization
system. Some countries may implement immunization
programme activities (e.g., child health days [15] or
campaigns) outside of the routine immunization system
that target children missed by routine immunization sys-
tems. As stated above, such doses are not included in
the estimated coverage levels and actual doses adminis-
tered would therefore be higher than estimated by the
coverage estimates.
Conclusions
Immunization, one of the most cost-effective public
health interventions [17,18], has made impressive contri-
butions to reducing child mortality. Though much pro-
gress has been achieved, if we are clear sighted in the
global vision for the future, we will acknowledge that
there is room for much improvement. The benefits of
vaccination continue to elude many of the world’s chil-
dren (during 2010 an estimated 19.3 million infants did
not receive the three doses of DTP [19]). Furthermore,
large differences in immunization coverage observed
here between countries are compounded by disparities
within countries. At the mid-term of the Global Immu-
nization Vision and Strategy, we observed more than
three-quarters of countries either achieved ≥ 90% cover-
age by 2010 or were on track to achieve ≥ 90% coverage
by 2015 for both DTP3 and MCV. Unfortunately, chal-
lenges remain among developing or least developed
countries with one-third of these countries not attaining
90% coverage. Nearly a quarter of 68 priority countries
made no progress during the first five years of GIVS.
Although there have been enormous and increasingly
successful efforts to address the global burden of vac-
cine-preventable diseases and to increase immunization
coverage, opportunities remain to improve routine
immunization coverage globally. While all countries
must make efforts to sustain their programmes, special
attention will need to be directed towards those coun-
tries that are unlikely to achieve 90% coverage by 2015.
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